Back
Biomarin Pharmaceutical Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65
BMRN
Biomarin Pharmaceutical
Last Price:
$71.39
Seasonality Move:
2.18%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Biomarin Pharmaceutical Stock Forecast
-
Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 15.3% based on the past 25 years of stock performance.
-
Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Biomarin Pharmaceutical Stock Undervalued?The current Biomarin Pharmaceutical [BMRN] share price is $71.44. The Score for BMRN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Biomarin Pharmaceutical Stock Go Up Next Year?
-
Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 15.3% based on the past 25 years of stock performance.
Biomarin Pharmaceutical Stock Rating
Buy
65
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical overpriced?
-
Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Biomarin Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
94.85
52-Week Low:
60.63
Prediction Charts
Market Cap:
13.6B
Price in USD:
71.44
Volume:
1.2M
Beta:
0.87
Technical Analysis
SMA50:
67.08
SMA100:
66.45
SMA200:
73.66
52-Wk Change:
-18.2%
Stock Predictions
-
Is Biomarin Pharmaceutical stock public?Yes, Biomarin Pharmaceutical is a publicly traded company.
-
What is the Biomarin Pharmaceutical stock quote today?The Biomarin Pharmaceutical stock price is 71.44 USD today.
-
How to buy Biomarin Pharmaceutical stock online?You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-11 | 71.54 | 70.49 | 72.35 | 70.05 |
| Mar-12 | 70.00 | 70.54 | 70.82 | 69.64 |
| Mar-13 | 70.44 | 70.60 | 71.93 | 70.19 |
| Mar-14 | 70.41 | 69.44 | 70.41 | 68.42 |
| Mar-17 | 69.60 | 71.55 | 71.63 | 69.23 |
| Mar-18 | 71.27 | 71.52 | 72.18 | 70.83 |
| Mar-19 | 71.52 | 71.32 | 72.08 | 70.92 |
| Mar-20 | 71.09 | 71.60 | 72.24 | 70.82 |
| Mar-21 | 71.55 | 71.24 | 72.06 | 70.68 |
| Mar-24 | 71.29 | 71.99 | 72.37 | 71.29 |
| Mar-25 | 72.13 | 71.53 | 72.26 | 70.94 |
| Mar-26 | 71.58 | 71.48 | 71.92 | 69.60 |
| Mar-27 | 71.99 | 72.83 | 73.18 | 71.87 |
| Mar-28 | 72.59 | 71.44 | 72.81 | 70.82 |
Biomarin Pharmaceutical Earnings
Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biomarin Pharmaceutical Forecast Revenue Growth
Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.13 per share, an increase this year of $1.01 per share, and an increase next year of $1.04 per share.
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.